The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jacobs John C since 2021.
This trader's CIK number is 1820836.
At the time of last reporting, Jacobs John C was the President and CEO of Novavax Inc. (stock ticker symbol NVAX).
Also see all insider trading activities at Novavax Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | HRMY | 0 | $0 | 148,700 | $6,888,756 | 148,700 | $1,222,313 |
2021 | HRMY | 0 | $0 | 51,300 | $1,912,487 | 51,300 | $421,686 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | NVAX | 0 | $0 | 0 | $0 | 166,530 | $0 |
2024 | NVAX | 0 | $0 | 0 | $0 | 83,197 | $0 |
1. Harmony Biosciences Holdings, Inc. (HRMY)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-08-15 | HRMY | Option Ex | 40,000 | 8.22 | 328,800 |
2022-08-15 | HRMY | Sale | 40,000 | 51.41 | 2,056,360 |
2022-06-15 | HRMY | Sale | 15,000 | 45.76 | 686,340 |
2022-06-15 | HRMY | Option Ex | 15,000 | 8.22 | 123,300 |
2022-06-13 | HRMY | Option Ex | 25,000 | 8.22 | 205,500 |
2022-06-13 | HRMY | Sale | 25,000 | 44.08 | 1,102,000 |
2022-03-16 | HRMY | Option Ex | 15,000 | 8.22 | 123,300 |
2022-03-16 | HRMY | Sale | 15,000 | 45.32 | 679,815 |
2022-03-14 | HRMY | Sale | 25,000 | 42.73 | 1,068,250 |
2022-03-14 | HRMY | Option Ex | 25,000 | 8.22 | 205,500 |
2022-01-03 | HRMY | Option Ex | 10,647 | 8.22 | 87,518 |
2022-01-04 | HRMY | Option Ex | 18,053 | 8.22 | 148,395 |
2022-01-03 | HRMY | Sale | 10,647 | 45.17 | 480,935 |
2022-01-04 | HRMY | Sale | 18,053 | 45.15 | 815,056 |
2021-12-27 | HRMY | Sale | 1,300 | 45.03 | 58,539 |
2021-12-27 | HRMY | Option Ex | 1,300 | 8.22 | 10,686 |
2021-12-13 | HRMY | Option Ex | 25,000 | 8.22 | 205,500 |
2021-12-13 | HRMY | Sale | 25,000 | 38.23 | 955,674 |
2021-09-13 | HRMY | Option Ex | 25,000 | 8.22 | 205,500 |
2021-09-13 | HRMY | Sale | 25,000 | 35.93 | 898,274 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-01 | NVAX | Option Ex | 83,334 | .00 | 0 |
2025-01-23 | NVAX | Option Ex | 83,196 | .00 | 0 |
2024-01-23 | NVAX | Option Ex | 83,197 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jacobs John C (President and CEO of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.